Royal Bank of Canada
MRK icon

Royal Bank of Canada’s Merck MRK Stock Holding History

Royal Bank of Canada’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.59B Buy
13,201,722
+11,637
+0.1% +$1.34M 0.28% 67
2025
Q4 		$1.39B Buy
13,190,085
+381,742
+3% +$35.8M 0.23% 80
2025
Q3 		$1.08B Sell
12,808,343
-744,797
-5% -$61.3M 0.18% 102
2025
Q2 		$1.07B Sell
13,553,140
-625,009
-4% -$49.7M 0.19% 100
2025
Q1 		$1.27B Sell
14,178,149
-4,197,825
-23% -$392M 0.27% 75
2024
Q4 		$1.83B Buy
18,375,974
+1,802,313
+11% +$186M 0.37% 55
2024
Q3 		$1.88B Buy
16,573,661
+880,615
+6% +$105M 0.38% 50
2024
Q2 		$1.94B Buy
15,693,046
+2,137,895
+16% +$275M 0.44% 44
2024
Q1 		$1.79B Sell
13,555,151
-1,416,923
-9% -$175M 0.41% 50
2023
Q4 		$1.63B Buy
14,972,074
+1,696,151
+13% +$176M 0.38% 56
2023
Q3 		$1.37B Sell
13,275,923
-1,183,743
-8% -$128M 0.37% 57
2023
Q2 		$1.67B Sell
14,459,666
-472,228
-3% -$53.6M 0.44% 46
2023
Q1 		$1.59B Sell
14,931,894
-690,216
-4% -$74.5M 0.45% 44
2022
Q4 		$1.73B Sell
15,622,110
-1,542,822
-9% -$158M 0.5% 42
2022
Q3 		$1.48B Sell
17,164,932
-349,669
-2% -$31.2M 0.47% 38
2022
Q2 		$1.6B Buy
17,514,601
+459,389
+3% +$40.7M 0.47% 39
2022
Q1 		$1.4B Buy
17,055,212
+302,510
+2% +$23.9M 0.35% 56
2021
Q4 		$1.28B Buy
16,752,702
+3,421,845
+26% +$273M 0.29% 73
2021
Q3 		$1B Sell
13,330,857
-92,690
-0.7% -$7.05M 0.26% 82
2021
Q2 		$1.04B Sell
13,423,547
-2,675,762
-17% -$199M 0.28% 76
2021
Q1 		$1.18B Sell
16,099,309
-6,309,488
-28% -$465M 0.34% 60
2020
Q4 		$1.75B Buy
22,408,797
+928,737
+4% +$71M 0.51% 37
2020
Q3 		$1.7B Buy
21,480,060
+1,083,031
+5% +$84.8M 0.61% 32
2020
Q2 		$1.51B Buy
20,397,029
+2,739,217
+16% +$206M 0.6% 29
2020
Q1 		$1.3B Buy
17,657,812
+1,983,426
+13% +$156M 0.62% 30
2019
Q4 		$1.36B Buy
15,674,386
+12,128
+0.1% +$996K 0.49% 38
2019
Q3 		$1.26B Buy
15,662,258
+637,754
+4% +$51.1M 0.5% 38
2019
Q2 		$1.2B Buy
15,024,504
+1,410,915
+10% +$108M 0.48% 40
2019
Q1 		$1.08B Sell
13,613,589
-696,784
-5% -$52.1M 0.46% 40
2018
Q4 		$1.04B Buy
14,310,373
+1,805,085
+14% +$127M 0.5% 36
2018
Q3 		$848M Sell
12,505,288
-386,218
-3% -$24.6M 0.35% 53
2018
Q2 		$747M Buy
12,891,506
+19,062
+0.1% +$1.08M 0.34% 58
2018
Q1 		$669M Buy
12,872,444
+79,940
+0.6% +$4.32M 0.3% 64
2017
Q4 		$687M Sell
12,792,504
-1,175,657
-8% -$65.2M 0.3% 66
2017
Q3 		$853M Buy
13,968,161
+1,000,328
+8% +$60.6M 0.41% 40
2017
Q2 		$793M Buy
12,967,833
+1,908,007
+17% +$116M 0.41% 40
2017
Q1 		$671M Buy
11,059,826
+443,904
+4% +$26.9M 0.36% 50
2016
Q4 		$596M Buy
10,615,922
+491,083
+5% +$28.7M 0.32% 56
2016
Q3 		$603M Buy
10,124,839
+314,132
+3% +$18.4M 0.34% 48
2016
Q2 		$539M Sell
9,810,707
-496,142
-5% -$26.4M 0.32% 56
2016
Q1 		$520M Sell
10,306,849
-1,319,415
-11% -$64.6M 0.32% 53
2015
Q4 		$586M Buy
11,626,264
+1,338,136
+13% +$67.5M 0.39% 45
2015
Q3 		$485M Buy
10,288,128
+281,693
+3% +$15M 0.36% 42
2015
Q2 		$544M Buy
10,006,435
+846,273
+9% +$47.5M 0.38% 40
2015
Q1 		$502M Buy
9,160,162
+105,617
+1% +$5.98M 0.35% 42
2014
Q4 		$491M Sell
9,054,545
-941,010
-9% -$52.4M 0.32% 51
2014
Q3 		$565M Buy
9,995,555
+2,854
+0% +$160K 0.39% 40
2014
Q2 		$552M Buy
9,992,701
+812,814
+9% +$44.3M 0.37% 37
2014
Q1 		$497M Buy
9,179,887
+1,028,378
+13% +$53.3M 0.37% 45
2013
Q4 		$389M Buy
8,151,509
+418,236
+5% +$19.1M 0.28% 53
2013
Q3 		$351M Sell
7,733,273
-510,176
-6% -$23.3M 0.27% 52
2013
Q2 		$365M Buy
+8,243,449
New +$368M 0.31% 49

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada's MRK Position: Q1 2026 in Review

Royal Bank of Canada increased its Merck (MRK) stake by 0.09% in Q1 2026, buying an estimated $1.34M and bringing the position to 13,201,722 shares worth $1.59B. The position accounts for 0.28% of the portfolio, ranked #67.

Royal Bank of Canada first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.94B in Q2 2024. 3,781 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Royal Bank of Canada held 13,201,722 shares of Merck worth $1.59B as of Q1 2026.
  • Royal Bank of Canada bought 11,637 Merck shares in Q1 2026, an estimated $1.34M.
  • Merck made up 0.28% of Royal Bank of Canada's portfolio in Q1 2026, its #67 holding.
  • Royal Bank of Canada first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Merck position peaked at $1.94B in Q2 2024.
  • 3,781 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.